Cargando…
The effect of intravenous trehalose administration in a patient with multiple sulfatase deficiency
INTRODUCTION: We describe the case of a female child with multiple sulfatase deficiency (MSD) who received intravenous (IV) trehalose (15 g/week) for 3 months. METHODS: The efficacy of trehalose was evaluated by comparing serum biomarkers, a quality-of-life questionnaire (HRQoL), and imaging (brain...
Autores principales: | Radbakhsh, Shabnam, Mobini, Moein, Gumpricht, Eric, Banach, Maciej, Jamialahmadi, Tannaz, Sahebkar, Amirhossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507772/ https://www.ncbi.nlm.nih.gov/pubmed/37732042 http://dx.doi.org/10.5114/aoms/159711 |
Ejemplares similares
-
Impact of Intravenous Trehalose Administration in Patients with Niemann–Pick Disease Types A and B
por: Mobini, Moein, et al.
Publicado: (2022) -
The Effects of N-Acetyl-L-Leucine on the Improvement of Symptoms in a Patient with Multiple Sulfatase Deficiency
por: Saberi-Karimian, Maryam, et al.
Publicado: (2022) -
Impact of bariatric surgery on circulating PCSK9 levels as a marker of cardiovascular disease risk: a meta-analysis
por: Jamialahmadi, Tannaz, et al.
Publicado: (2022) -
Statins and C-reactive protein: in silico evidence on direct interaction
por: Shakour, Neda, et al.
Publicado: (2020) -
The effects of oral trehalose on glycaemia, inflammation, and quality of life in patients with type 2 diabetes: a pilot randomized controlled trial
por: Hashemian, Somayyeh, et al.
Publicado: (2023)